About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 9 record(s)
Req # A-2020-000953
The list of the number of registration certificates authorizing the production of Cannabis for personal possession and/or for medical use in the City of Saint-Colomban area.Organization: Health Canada
November 2020
Req # A-2020-000059
In relation to the Non-Insured Health Benefits Program (the “NIHB”), all final letters, memoranda, memoranda to Cabinet, briefing notes, strategic plans, data/analyses, reports/evaluations, opinions or agreements (including funding agreements),Organization: Health Canada
September 2020
Req # A-2019-001561
A record which indicates whether the 2 octreotide acetate submissions posted on the Generic Submissions Under Review (GSUR) listing pertain to a single manufacturer or not.Organization: Health Canada
March 2020
Req # A-2019-000740
All documents submitted by Sandoz Canada Inc. in Electronic Common Technical Document (eCTD) Module 1.6.1 (Comparative Bioavailability Information) of any Abbreviated New Drug Submissions made by Sandoz Canada Inc. for its GLATOPA product (glatiramer acetate).Organization: Health Canada
February 2020
Req # A-2019-001413
All records, from 2015 to November 19, 2019, sent by Imperial Tobacco Canada Limited to Health Canada under the Tobacco Reporting Regulations.Organization: Health Canada
February 2020
Req # A-2018-000950
Any one document that provides the batch number(s) of all REVLIMID used in the comparative studies included in the APO-LENALIDOMIDE abbreviated new drug submission number 218298.Organization: Health Canada
January 2020
Req # A-2019-000752
Health Canada Compliance report delivered to CannTrust.Organization: Health Canada
January 2020
Req # A-2019-000521
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-106665-371.Organization: Health Canada
January 2020
Req # A-2019-001374
Any New Drug Submission (NDS), regarding new drugs containing ferric carboxymaltose, also named iron carboxymaltose or iron dextri-maltose: - The related exchanges between Health Canada and the sponsor and the minutes and presentation materials of any meeting between Health Canada and the sponsor.Organization: Health Canada
January 2020